Airway management

American Canadian School of Medicine Partners with Community to Train Fire Department

Retrieved on: 
Wednesday, February 14, 2024

PORTSMOUTH, Dominica, Feb. 14, 2024 /PRNewswire-PRWeb/ -- The American Canadian School of Medicine (ACSOM) is pleased to announce a new partnership with the Dominica Fire and Ambulance Services Portsmouth Unit conducting a training initiative with 12 fire officers.

Key Points: 
  • The American Canadian School of Medicine (ACSOM) is pleased to announce a new partnership with the Dominica Fire and Ambulance Services Portsmouth Unit conducting a training initiative with 12 fire officers.
  • PORTSMOUTH, Dominica, Feb. 14, 2024 /PRNewswire-PRWeb/ -- The American Canadian School of Medicine (ACSOM) is pleased to announce a new partnership with the Dominica Fire and Ambulance Services Portsmouth Unit conducting a training initiative with 12 fire officers.
  • "We are proud to collaborate with the local fire department in this important training endeavor," said Dr. Bauman.
  • The partnership underscores ACSOM's commitment to community health, safety and education as well as our commitment to supporting local emergency responders.

Sleep Doctor partners with Airway Management to offer myTAP® Oral Appliance

Retrieved on: 
Wednesday, February 7, 2024

DALLAS, Feb. 7, 2024 /PRNewswire/ -- Airway Management, manufacturer of the most globally researched oral appliances, is excited to announce myTAP is now available through Sleep Doctor. This partnership is to help consumers suffering from snoring or sleep apnea or who may be CPAP non-compliant.

Key Points: 
  • DALLAS, Feb. 7, 2024 /PRNewswire/ -- Airway Management, manufacturer of the most globally researched oral appliances, is excited to announce myTAP is now available through Sleep Doctor .
  • Sleep Doctor is an online sleep wellness company dedicated to enabling millions of individuals each year to make well-informed choices on improving sleep.
  • By providing virtual consultations with doctors, at-home sleep testing, and top-notch treatment choices, Sleep Doctor is a comprehensive destination for consumers aiming to harness the power of quality sleep.
  • "We are thrilled to announce that Sleep Doctor is joining forces with Airway Management in a strategic partnership that will amplify our strengths in the sleep world," says the Sleep Doctor clinical team.

Global Airway Management Devices Market Report 2023-2033: Rising Demand for Advanced Airway Management Devices Driven by Surgical Surges and Chronic Illnesses

Retrieved on: 
Tuesday, January 9, 2024

The escalating demand for airway management devices is primarily propelled by the increasing prevalence of respiratory conditions, particularly Chronic Obstructive Pulmonary Disease (COPD).

Key Points: 
  • The escalating demand for airway management devices is primarily propelled by the increasing prevalence of respiratory conditions, particularly Chronic Obstructive Pulmonary Disease (COPD).
  • Geographically, North America is poised to emerge as a major contributor to the growth of the airway management devices market.
  • What are the major market drivers, challenges and opportunities in the global airway management devices market and their case studies?
  • What is the market share of the leading segments and sub-segments of the global airway management devices market?

CMS Grants Transitional Pass-Through (TPT) Payment for Ambu’s aScope 5 Broncho HD Single-Use Bronchoscope

Retrieved on: 
Wednesday, December 6, 2023

Ambu Inc. announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted the company’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.

Key Points: 
  • Ambu Inc. announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted the company’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.
  • View the full release here: https://www.businesswire.com/news/home/20231206904736/en/
    The U.S. Centers for Medicare & Medicaid Services (CMS) has granted Ambu’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.
  • The aScope 5 Broncho HD is a best-in-class single-use bronchoscopy system with high-performance functionality and imaging, combined with single-use’s distinct productivity and safety advantages.
  • TPT was granted to the aScope 5 Broncho HD series because it fit CMS criteria, which included demonstrating a substantial clinical improvement over existing single-use and reusable bronchoscopy technology.

Respiratory Disease Testing Market Size & Trends Analysis 2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 28, 2023

The "Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030
    The market is driven by the rising prevalence of respiratory diseases.
  • Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.
  • These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen

Retrieved on: 
Friday, October 13, 2023

Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen, has been granted a De Novo by the FDA.

Key Points: 
  • Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen, has been granted a De Novo by the FDA.
  • Enabled by the multi-wavelength Masimo rainbow® Pulse CO-Oximetry platform, ORi is designed for use in conjunction with oxygen saturation (SpO2) to provide increased resolution of changes in oxygenation under supplemental oxygen.
  • View the full release here: https://www.businesswire.com/news/home/20231013679815/en/
    Without ORi, there is no noninvasive way to monitor oxygenation under supplemental oxygen to manage hyperoxia, or higher than normal oxygenation of arterial blood.
  • By convention, SpO2 is limited to an upper limit of 100%, but oxygenation can rise into hyperoxia when supplemental oxygen is administered.

Teleflex Awarded National Group Purchasing Agreements with Premier, Inc.

Retrieved on: 
Tuesday, July 25, 2023

WAYNE, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded three group purchasing agreements with Premier, Inc.

Key Points: 
  • WAYNE, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded three group purchasing agreements with Premier, Inc.
  • Effective August 1st, 2023, the new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products in the Laryngoscope Systems, Laryngeal Masks Airways, and Disposable Anesthesia Products categories.
  • Teleflex, through its Rüsch™ and LMA™ products, provides healthcare providers solutions to optimize patient outcomes by offering broad portfolios to meet every day airway needs.
  • The group purchasing agreements include access to Rüsch™ and Sheridan™ endotracheal tubes, nasal and oral airways, and LMA™ supraglottic devices.

Airway Management Launches its Morf Nasal Mask: The First Custom Nasal Mask on the Market

Retrieved on: 
Monday, June 26, 2023

DALLAS, June 26, 2023 /PRNewswire/ -- Airway Management, leading innovator in sleep therapy products and manufacturer of the most globally researched custom oral appliances, is thrilled to announce the launch of its Morf Nasal CPAP Mask. Designed to enhance comfort and sustainability, this revolutionary mask incorporates a silicone-free biodegradable seal, setting a new standard in the industry.

Key Points: 
  • DALLAS, June 26, 2023 /PRNewswire/ -- Airway Management, leading innovator in sleep therapy products and manufacturer of the most globally researched custom oral appliances, is thrilled to announce the launch of its Morf Nasal CPAP Mask .
  • Designed to enhance comfort and sustainability, this revolutionary mask incorporates a silicone-free biodegradable seal, setting a new standard in the industry.
  • "We are thrilled to introduce the Morf Nasal CPAP Mask to the market," said Charles Collins, CEO at Airway Management.
  • Key features of the Morf Nasal CPAP Mask include:
    Silicone-Free Design: The mask is crafted from hypoallergenic, latex-free materials, ensuring a comfortable fit without the risk of skin irritation or allergic reactions.

Teleflex Announces Partnership with Insighters Medical for Exclusive Distribution of the Insighters® Video Laryngoscope System

Retrieved on: 
Wednesday, June 21, 2023

WAYNE, Pa., June 21, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. as the exclusive U.S. distributor of the Insighters® Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.

Key Points: 
  • WAYNE, Pa., June 21, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. as the exclusive U.S. distributor of the Insighters® Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.
  • The Insighters® Video Laryngoscope system of interchangeable accessories and components supports endotracheal tube placement in a variety of intubation scenarios, while allowing clinicians to share and record real-time high-resolution images and video.
  • The Insighters® Video Laryngoscope System joins the portfolio of industry-leading Airway Management devices available from Teleflex for everyday airway procedures.
  • The Insighters® Video Laryngoscope system incorporates innovative technologies with interchangeable components to address a multitude of clinical preference with a single system,” said Kevin Robinson, President and General Manager, Anesthesia and Emergency Medicine Division, Teleflex Incorporated.

Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment

Retrieved on: 
Thursday, June 8, 2023

Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV) , one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of its pre-surgical patient assessment research program.

Key Points: 
  • Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV) , one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of its pre-surgical patient assessment research program.
  • Masimo W1, which offers accurate, continuous measurements of key physiological parameters, is available in Europe as a medical device that integrates with the Masimo SafetyNet® remote patient management platform.
  • The baseline data can then allow clinicians to know what is normal and abnormal for each patient they care for in the hospital.
  • Also, with Masimo W1, they can remotely monitor the patient post surgery at home when appropriate and reduce how long the patient remains in the hospital.